Reynold Panettieri


Steve Hockstein

A multi-university team—led by Rutgers—has been awarded a National Institutes of Health grant to join the institute’s Clinical and Translational Science Awards Program. It will increase Rutgers’ access to clinical trials, help introduce new therapies, and create opportunities for more funding. “The ultimate goal is bringing more evidence-based treatments to more patients more quickly,” says Reynold Panettieri (pictured), the vice chancellor for translational medicine and science and director of the Rutgers Institute for Translational Medicine and Science. The program supports a national network of 50 medical research institutions that collaborate to shorten the time between basic science breakthroughs and life-saving clinical treatments.